Constipation is listed among common gastrointestinal adverse reactions with semaglutide, the GLP-1 receptor agonist used in Wegovy
Proactive strategies can minimise gout risk for patients taking Wegovy, particularly during the initial months when weight loss is most rapid
Killing off the bacteria is helpful in clearing up breakouts, but without treating the overactive oil glands, this treatment usually doesnt produce the kind of long-lasting results patients are looking for
Appetite Regulation GLP-1 therapy works by influencing the brains appetite centers, reducing hunger and controlling cravings
18 LiangQ.ShenN.LaiB.XuC.SunZ.WangZ.et al (2019)
Enhanced tumor growth in brain dopamine-depleted mice following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) treatment